These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26259412)

  • 1. [Cardiac Manifestations in Antiphospholipid Syndrome--A Brief Review of the Literature].
    Djoković A; Stojanović L
    Srp Arh Celok Lek; 2015; 143(5-6):346-53. PubMed ID: 26259412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac manifestations in antiphospholipid syndrome.
    Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
    Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form.
    Kolitz T; Shiber S; Sharabi I; Winder A; Zandman-Goddard G
    Front Immunol; 2019; 10():941. PubMed ID: 31134062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin.
    Markousis-Mavrogenis G; Sfikakis PP; Mavrogeni SI; Tektonidou MG
    Clin Rheumatol; 2021 Jul; 40(7):2559-2568. PubMed ID: 33196982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Disease in Antiphospholipid Syndrome.
    Polytarchou K; Varvarousis D; Manolis AS
    Curr Vasc Pharmacol; 2020; 18(6):538-548. PubMed ID: 31530257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies: lessons from the bench.
    Koike T; Bohgaki M; Amengual O; Atsumi T
    J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies in systemic lupus erythematosus and the antiphospholipid syndrome.
    Setty YN; Komatireddy GR
    Front Biosci; 2001 Dec; 6():E207-12. PubMed ID: 11724683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac involvement in the antiphospholipid syndrome.
    Tenedios F; Erkan D; Lockshin MD
    Lupus; 2005; 14(9):691-6. PubMed ID: 16218469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome.
    George D; Erkan D
    Prog Cardiovasc Dis; 2009; 52(2):115-25. PubMed ID: 19732604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The geoepidemiology of the antiphospholipid antibody syndrome.
    Biggioggero M; Meroni PL
    Autoimmun Rev; 2010 Mar; 9(5):A299-304. PubMed ID: 19932199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.